Seres Therapeutics, Inc. (MCRB)

Last Three Months

27-Jan-24 -- 26-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Reduce

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

16

0

6

+1

0

+2

0

+3

Two Year Chart

27-Apr-22 -- 26-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
16-Feb-24 9:48 PM View:	16-Feb-24 Planned Option Sale ($4.25K)	Desrosier Thomas Chief Legal Officer and EVP		Seres Therapeutics, Inc. - MCRB	6% 113.89K to 120.58K	0	0	--	--	Show Txns Hide Txns

16-Feb-24 9:31 PM View:	16-Feb-24 Planned Option Sale ($4.50K)	Henn Matthew R. See Remarks		Seres Therapeutics, Inc. - MCRB	13% 56.36K to 63.44K	0	0	--	--	Show Txns Hide Txns

16-Feb-24 9:21 PM View:	16-Feb-24 Planned Option Sale ($4.75K)	von Moltke Lisa See Remarks		Seres Therapeutics, Inc. - MCRB	79% 9.51K to 16.99K	0	0	--	--	Show Txns Hide Txns

16-Feb-24 9:29 PM View:	16-Feb-24 Planned Option Sale ($3.64K)	Young Teresa L. See Remarks		Seres Therapeutics, Inc. - MCRB	86% 8.45K to 15.71K	0	0	--	--	Show Txns Hide Txns

16-Feb-24 9:15 PM View:	16-Feb-24 Planned Option Sale ($5.41K)	Ege David S. See Remarks		Seres Therapeutics, Inc. - MCRB	10% 66.99K to 73.86K	0	0	--	--	Show Txns Hide Txns

16-Feb-24 9:42 PM View:	16-Feb-24 Planned Option Sale ($12.47K)	Shaff Eric D. CEO and President Director		Seres Therapeutics, Inc. - MCRB	17% 115.62K to 135.32K	0	0	--	--	Show Txns Hide Txns

16-Feb-24 9:13 PM View:	16-Feb-24 Planned Option Sale ($4.25K)	Arkowitz David Chief Financial Officer		Seres Therapeutics, Inc. - MCRB	4% 175.76K to 182.44K	0	0	--	--	Show Txns Hide Txns